RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Ana M. Espino to Fascioliasis

This is a "connection" page, showing publications Ana M. Espino has written about Fascioliasis.
Connection Strength

3.855
  1. Aguayo V, Valdes B, Espino AM. Assessment of Fasciola hepatica glutathione S-transferase as an antigen for serodiagnosis of human chronic fascioliasis. Acta Trop. 2018 Oct; 186:41-49.
    View in: PubMed
    Score: 0.576
  2. Rivera F, Espino AM. Adjuvant-enhanced antibody and cellular responses to inclusion bodies expressing FhSAP2 correlates with protection of mice to Fasciola hepatica. Exp Parasitol. 2016 Jan; 160:31-8.
    View in: PubMed
    Score: 0.481
  3. Cab?n-Hern?ndez K, Gaudier JF, Ruiz-Jim?nez C, Espino AM. Development of two antibody detection enzyme-linked immunosorbent assays for serodiagnosis of human chronic fascioliasis. J Clin Microbiol. 2014 Mar; 52(3):766-72.
    View in: PubMed
    Score: 0.420
  4. Morales A, Espino AM. Evaluation and characterization of Fasciola hepatica tegument protein extract for serodiagnosis of human fascioliasis. Clin Vaccine Immunol. 2012 Nov; 19(11):1870-8.
    View in: PubMed
    Score: 0.386
  5. Figueroa-Santiago O, Delgado B, Espino AM. Fasciola hepatica saposin-like protein-2-based ELISA for the serodiagnosis of chronic human fascioliasis. Diagn Microbiol Infect Dis. 2011 Jul; 70(3):355-61.
    View in: PubMed
    Score: 0.354
  6. Espino AM, Morales A, Delgado B, Rivera FM, Figueroa O, Su?rez E. Partial immunity to Fasciola hepatica in mice after vaccination with FhSAP2 delivered as recombinant protein or DNA construct. Ethn Dis. 2010; 20(1 Suppl 1):S1-17-23.
    View in: PubMed
    Score: 0.319
  7. Espino AM, Rivera F. Quantitation of cytokine mRNA by real-time RT-PCR during a vaccination trial in a rabbit model of fascioliasis. Vet Parasitol. 2010 Apr 19; 169(1-2):82-92.
    View in: PubMed
    Score: 0.319
  8. Espino AM, Hillyer GV. A novel Fasciola hepatica saposinlike recombinant protein with immunoprophylactic potential. J Parasitol. 2004 Aug; 90(4):876-9.
    View in: PubMed
    Score: 0.219
  9. Espino AM, Hillyer GV. Molecular cloning of a member of the Fasciola hepatica saposin-like protein family. J Parasitol. 2003 Jun; 89(3):545-52.
    View in: PubMed
    Score: 0.202
  10. Ramos-Ben?tez MJ, Lopez-Cruz LM, Aguayo V, Ruiz-Jimenez C, Espino AM. Cell-free expression, purification and immunoreactivity assessment of recombinant Fasciola hepatica saposin-like protein-2. Mol Biol Rep. 2018 Oct; 45(5):1551-1556.
    View in: PubMed
    Score: 0.144
  11. Shin SH, Hsu A, Chastain HM, Cruz LA, Elder ES, Sapp SG, McAuliffe I, Espino AM, Handali S. Development of Two FhSAP2 Recombinant-Based Assays for Immunodiagnosis of Human Chronic Fascioliasis. Am J Trop Med Hyg. 2016 Oct 05; 95(4):852-855.
    View in: PubMed
    Score: 0.127
  12. Gaudier JF, Cab?n-Hern?ndez K, Osuna A, Espino AM. Biochemical characterization and differential expression of a 16.5-kilodalton tegument-associated antigen from the liver fluke Fasciola hepatica. Clin Vaccine Immunol. 2012 Mar; 19(3):325-33.
    View in: PubMed
    Score: 0.092
  13. Cab?n-Hern?ndez K, Gaudier JF, Espino AM. Characterization and differential expression of a ferritin protein from Fasciola hepatica. Mol Biochem Parasitol. 2012 Mar-Apr; 182(1-2):54-61.
    View in: PubMed
    Score: 0.092
  14. Torres D, Espino AM. Mapping of B-cell epitopes on a novel 11.5-kilodalton Fasciola hepatica-Schistosoma mansoni cross-reactive antigen belonging to a member of the F. hepatica saposin-like protein family. Infect Immun. 2006 Aug; 74(8):4932-8.
    View in: PubMed
    Score: 0.063
  15. Espino AM, Osuna A, Gil R, Hillyer GV. Fasciola hepatica: humoral and cytokine responses to a member of the saposin-like protein family following delivery as a DNA vaccine in mice. Exp Parasitol. 2005 Aug; 110(4):374-83.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support